Table 1.
Patient demographics including age and race gathered from all four New York City public hospitals
| Patient characteristics | Pre-COVID N= 353 | COVID N= 51 | p-value |
|---|---|---|---|
| Age (%) | < 0.001 | ||
| < 30 | 3 ( 0.8) | 2 ( 3.9) | |
| 31 - 40 | 24 ( 6.8) | 3 ( 5.9) | |
| 41 - 50 | 94 (26.6) | 12 ( 23.5) | |
| 51 - 60 | 102 (28.9) | 17 ( 33.3) | |
| 61 - 70 | 86 (24.4) | 10 ( 19.6) | |
| 71 - 80 | 29 ( 8.2) | 6 ( 11.8) | |
| > 81 | 15 ( 4.2) | 1 ( 2.0) | |
| Race (n (%)) | < 0.001 | ||
| Asian/Pacific Islander | 30 ( 8.5) | 7 ( 13.7) | |
| Black | 107 (30.3) | 15 ( 29.4) | |
| Hispanic/Latino | 6 ( 1.7) | 20 ( 39.2) | |
| Other/Unknown | 124 (35.1) | 4 ( 7.8) | |
| White | 86 (24.4) | 5 ( 9.8) | |
Patients were analyzed according to their membership to the pre-COVID cohort (cancer diagnosed between 1 January 2017 and 30 June 2018) versus the COVID cohort (cancer diagnosed between 1 January and 30 June 2020)